Empire Life Investments Inc. Johnson & Johnson Transaction History

Empire Life Investments Inc.

$1.58 Billion
Q2 2024

A detailed history of Empire Life Investments Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Empire Life Investments Inc. holds 208,531 shares of JNJ stock, worth $33.6 Million. This represents 1.93% of its overall portfolio holdings.

Number of Shares

208,531

Previous 218,300 4.48%

Holding current value

$33.6 Million

Previous $34.5 Million 11.74%

% of portfolio

1.93%

Previous 2.14%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$144.38 - $157.78 $1.41 Million - $1.54 Million	-9,769 Reduced 4.48%	208,531 $30.5 Million
Q1 2024 Apr 30, 2024	SELL	$155.22 - $162.74 $1.67 Million - $1.75 Million	-10,780 Reduced 4.71%	218,300 $34.5 Million
Q4 2023 Feb 08, 2024	SELL	$145.6 - $158.88 $973,044 - $1.06 Million	-6,683 Reduced 2.83%	229,080 $35.9 Million
Q3 2023 Nov 09, 2023	SELL	$155.75 - $174.48 $4.48 Million - $5.02 Million	-28,757 Reduced 10.87%	235,763 $36.7 Million
Q2 2023 Aug 10, 2023	SELL	$154.35 - $166.11 $1.42 Million - $1.53 Million	-9,193 Reduced 3.36%	264,520 $43.8 Million
Q1 2023 May 08, 2023	BUY	$151.05 - $180.26 $2.12 Million - $2.53 Million	14,051 Added 5.41%	273,713 $42.4 Million
Q4 2022 Feb 02, 2023	SELL	$160.2 - $179.79 $1.68 Million - $1.89 Million	-10,508 Reduced 3.89%	259,662 $45.9 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $396,710 - $441,439	2,459 Added 0.92%	270,170 $44.1 Million
Q2 2022 Aug 03, 2022	BUY	$168.19 - $186.01 $346,135 - $382,808	2,058 Added 0.77%	267,711 $47.5 Million
Q1 2022 May 11, 2022	SELL	$158.14 - $179.59 $709,099 - $805,281	-4,484 Reduced 1.66%	265,653 $47.1 Million
Q4 2021 Feb 09, 2022	SELL	$155.93 - $173.01 $317,629 - $352,421	-2,037 Reduced 0.75%	270,137 $46.2 Million
Q3 2021 Nov 09, 2021	SELL	$161.5 - $179.47 $9,367 - $10,409	-58 Reduced 0.02%	272,174 $44 Million
Q2 2021 Aug 04, 2021	SELL	$159.48 - $171.07 $543,188 - $582,664	-3,406 Reduced 1.24%	272,232 $44.8 Million
Q1 2021 Apr 29, 2021	SELL	$153.07 - $170.48 $2.9 Million - $3.24 Million	-18,978 Reduced 6.44%	275,638 $45.3 Million
Q4 2020 Feb 09, 2021	BUY	$137.11 - $157.38 $1.52 Million - $1.74 Million	11,061 Added 3.9%	294,616 $46.4 Million
Q3 2020 Nov 05, 2020	SELL	$140.38 - $153.83 $1.27 Million - $1.39 Million	-9,055 Reduced 3.09%	283,555 $42.2 Million
Q2 2020 Aug 03, 2020	SELL	$128.81 - $155.51 $1.33 Million - $1.61 Million	-10,331 Reduced 3.41%	292,610 $41.2 Million
Q1 2020 Apr 23, 2020	SELL	$111.14 - $153.99 $5.66 Million - $7.84 Million	-50,931 Reduced 14.39%	302,941 $39.7 Million
Q4 2019 Jan 21, 2020	BUY	$127.5 - $146.44 $18.4 Million - $21.2 Million	144,620 Added 69.11%	353,872 $51.6 Million
Q3 2019 Oct 25, 2019	SELL	$126.95 - $142.14 $3.22 Million - $3.61 Million	-25,386 Reduced 10.82%	209,252 $27.1 Million
Q2 2019 Aug 20, 2019	BUY	$131.15 - $144.24 $543,092 - $597,297	4,141 Added 1.8%	234,638 $32.7 Million
Q1 2019 Apr 17, 2019	BUY	$125.72 - $139.79 $1.32 Million - $1.47 Million	10,520 Added 4.78%	230,497 $32.2 Million
Q4 2018 Feb 04, 2019	BUY	$122.84 - $147.84 $3.43 Million - $4.13 Million	27,939 Added 14.55%	219,977 $28.4 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $1.55 Million - $1.82 Million	-12,725 Reduced 6.21%	192,038 $26.5 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $115,818 - $127,807	970 Added 0.48%	204,763 $24.8 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $554,568 - $656,704	4,433 Added 2.22%	203,793 $26.1 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $25,719 - $28,149	196 Added 0.1%	199,360 $27.9 Million
Q3 2017 Nov 14, 2017	SELL	$129.47 - $135.38 $789,637 - $825,682	-6,099 Reduced 2.97%	199,164 $25.9 Million
Q2 2017 Aug 14, 2017	BUY	N/A	205,263	205,263 $27.2 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $422B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Empire Life Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Empire Life Investments Inc. with notifications on news.

Account

Empire Life Investments Inc. Johnson & Johnson Transaction History